ASP2138

ASP2138 · Astellas Pharma Global Development, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ASP2138, covering 2026-03-13 to 2026-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer [Phase 1]

See pricing